Order results by:
| Issue | Title | |
| Vol 12, No 1 (2020) | Geroprotective properties of neuroprotective and neurotrophic peptides | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, V. G. Zgoda, A. I. Sorokin, O. V. Tikhonova | ||
| "... Objective: to elucidate whether cerebrolysin contains peptide fragments that promote geroprotection ..." | ||
| Vol 8, No 2 (2016) | Effect of cerebrolysin on motor function restoration during medical rehabilitation | Abstract similar documents |
| M. A. Kustova, A. P. Tolmachev, N. A. Shamalov | ||
| "... CARS that demonstrates the positive effect of cerebrolysin versus placebo according to the primary ..." | ||
| Vol 13, No 4 (2021) | Neuroprotective therapy in acute ischemic stroke | Abstract similar documents |
| A. A. Kulesh | ||
| "... , natalizumab, interleukin 1 receptors antagonists, cerebrolysin, and other drugs have been analyzed. Non-drug ..." | ||
| Vol 11, No 3 (2019) | Rehabilitation in acute stroke from the point of view of evidence-based medicine: possibilities of drug treatment | Abstract similar documents |
| A. A. Kulesh | ||
| "... , the efficiency of cerebrolysin in particular, are considered. ..." | ||
| Vol 7, No 4 (2015) | Neurotrophic and antioxidant potential of neuropeptides and trace elements | Abstract similar documents |
| O. A. Gromova, A. V. Pronin, I. Yu. Torshin, A. G. Kalacheva, T. R. Grishina | ||
| "... and the mechanisms of therapeutic action of cerebrolysin. ..." | ||
| Vol 9, No 2 (2017) | Chronic cerebral ischemia, neuroplasticity, possibilities of therapy | Abstract similar documents |
| E. I. Chukanova, A. S. Chukanova | ||
| "... of the neuropeptide drug Cerebrolysin are reviewed. The authors describe in detail the results of the clinical trial ..." | ||
| Vol 15, No 5 (2023) | Possibilities of combined use of peptides in the treatment of post-stroke asthenia | Abstract similar documents |
| A. Yu. Emelin, V. Yu. Lobzin | ||
| "... -stroke fatigue the drug Cytochrome C, which is a key peptide of the mitochondrial respiratory chain ..." | ||
| Vol 8, No 4 (2016) | ALZHEIMER’S DISEASE: DIAGNOSIS AND TREATMENT | Abstract similar documents |
| A. A. Naumenko, D. O. Gromova, N. V. Trofimova, I. S. Preobrazhenskaya | ||
| Vol 13, No 6 (2021) | Efficacy and safety of anti-CGRP(r) monoclonal antibodies in real clinical practice: preliminary analysis after three months of therapy | Abstract similar documents |
| N. V. Vashchenko, D. Z. Korobkova, K. V. Skorobogatykh, Yu. E. Azimova | ||
| "... Monoclonal antibodies inhibiting calcitonin gene related peptide (CGRP) or its receptor have been ..." | ||
| Vol 14, No 5 (2022) | Application of a new biological pathogenetic therapy of migraine in clinical practice: expert consensus of the Russian Headache Research Society | Abstract similar documents |
| A. V. Sergeev, G. R. Tabeeva, E. G. Filatova, A. V. Amelin, L. R. Akhmadeeva, E. R. Lebedeva, V. V. Osipova, Yu. E. Azimova, N. V. Latysheva, O. B. Doronina, K. V. Skorobogatykh | ||
| "... ) to the calcitonin gene related peptide (CGRP) ligand or receptor. These recommendations are based on current ..." | ||
| Vol 12, No 4 (2020) | Current concept of the pathophysiology of migraine and new targets for its therapy | Abstract PDF (Eng) similar documents |
| G. R. Tabeeva, Z. Katsapava | ||
| Vol 16, No 1 (2024) | Safety and efficacy of fremanezumab in real clinical practice in patients with chronic migraine | Abstract similar documents |
| G. N. Belskaya, A. V. Krasnikov, E. A. Kiryanova, M. E. Prokopovich, E. V. Sakharova, G. V. Makarov | ||
| Vol 7, No 2 (2015) | Treatment for chronic daily headache by using auxiliary and alternative methods | Abstract similar documents |
| V. A. Golovacheva, V. A. Parfenov, V. V. Zakharov | ||
| "... headache centers and clinics. It describes experience with cerebrolysin used as auxiliary and alternative ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Drug therapy and cognitive stimulation in patients with poststroke cognitive impairments | Abstract similar documents |
| D.R. Khasanova, Yu.V. Zhitkova, L.M. Yu.V. | ||
| "... ) actovegin infusions; 3) cerebrolysin infusions; 4) drug therapy in combination with non-drug cognitive ..." | ||
| Vol 16, No 2 (2024) | Refractory migraine | Abstract similar documents |
| G. R. Tabeeva, O. V. Kosivtsova, N. A. Kovalchuk, T. A. Orlyuk | ||
| "... . Currently, the use of monoclonal antibodies against calcitonin gene-related peptide is the best-studied ..." | ||
| Vol 15, No 1 (2023) | Chondroprotectors as modulators of neuroinflammation | Abstract similar documents |
| I. Y. Torshin, O. A. Gromova, A. G. Nazarenko | ||
| "... through activation of the PKC/PI3K/Akt signaling pathway; 5) inhibition of matrix metalloproteinases ..." | ||
| Vol 15, No 3 (2023) | Patient with non-cardioembolic ischemic stroke or high-risk transient ischemic attack. Part 2. Secondary prophylaxis | Abstract similar documents |
| A. A. Kulesh, S. N. Yanishevsky, D. A. Demin, L. I. Syromyatnikova, O. I. Vinogradov | ||
| "... glucagon-like peptide agonists with glycosylated hemoglobin level of <7%; prescribing antihypertensive ..." | ||
| Vol 12, No 4 (2020) | Diagnosis and treatment of migraine: Russian experts' recommendations | Abstract similar documents |
| E. G. Filatova, V. V. Osipova, G. R. Tabeeva, V. A. Parfenov, E. V. Ekusheva, Yu. E. Azimova, N. V. Latysheva, M. V. Naprienko, K. V. Skorobogatykh, A. V. Sergeev, V. A. Golovacheva, E. R. Lebedeva, A. R. Artyomenko, O. V. Kurushina, M. I. Koreshkina, A. V. Amelin, L. R. Akhmadeeva, A. R. Rachin, E. D. Isagulyan, Al. B. Danilov, A. B. Gekht | ||
| "... antibodies to calcitonin gene-related peptide or its receptors, is indicated for frequent or severe migraine ..." | ||
| Vol 13, No 5 (2021) | Pathobiochemical pathways of redox imbalance in the neurological long-term effects of COVID-19 and the role of chondroitin sulfate in the redox status restoration | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, A. V. Naumov | ||
| "... syndrome in patients with SARS-CoV2 infection are discussed (regulation of the PKC/PI3K/Akt activity ..." | ||
| Vol 16, No 3 (2024) | Analyzing the predictors of relapse in drug-induced headache: a prospective clinical and psychological study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... pathologies. It can be assumed that monoclonal antibodies against calcitonin gene-related peptides, botulinum ..." | ||
| Vol 12, No 6 (2020) | Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke | Abstract PDF (Eng) similar documents |
| S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, К. V. Sobyanin | ||
| "... -Btype natriuretic peptide (NT-proBNP) in embolic CS versus cardioembolic stroke (CES) and non ..." | ||
| 1 - 21 of 21 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
